ATI RN
ATI Endocrine Pharmacology Quizlet Questions
Question 1 of 5
A 26-year-old woman asked her family physician for a hormonal contraceptive. She refused other methods of contraception. Past history of the woman indicated disseminated intravascular coagulation that followed an abortion due to placental abruptio. Which of the following would be the most appropriate hormonal contraceptive preparation for this woman?
Correct Answer: B
Rationale: The correct answer is B: Ethinyl estradiol and norethindrone. This combination is a safer choice for the woman due to her history of disseminated intravascular coagulation following an abortion. Ethinyl estradiol and norethindrone have a lower risk of venous thromboembolism compared to other estrogen-containing contraceptives, making it a suitable option for this patient. Rationale for other choices: A: Diethylstilbestrol is contraindicated due to its association with an increased risk of thromboembolic events. C: Mestranol and norethindrone combination may also increase the risk of thromboembolic events, making it unsuitable for this patient. D: Mifepristone is not a hormonal contraceptive; it is used for medical abortion and emergency contraception, not for regular contraception.
Question 2 of 5
Which of the following would be an appropriate change in the treatment plan for a patient with osteoporosis and hypertension experiencing a significant decrease in bone mass despite current therapy?
Correct Answer: C
Rationale: The correct answer is C: Add calcitonin to the current regimen. Calcitonin helps to increase bone density and reduce bone loss in osteoporosis. This would address the significant decrease in bone mass. Choice A (substitute hydrochlorothiazide with propranolol) is incorrect as propranolol does not have a direct impact on bone mass. Choice B (substitute raloxifene with ethinyl estradiol) is incorrect as ethinyl estradiol is not typically used for osteoporosis and may not be effective. Choice D (increase the daily dose of calcium carbonate) is incorrect as simply increasing calcium intake may not be sufficient to address the bone loss, especially in the presence of inadequate bone formation. Adding calcitonin addresses the root cause of bone loss in osteoporosis and is therefore the appropriate change in the treatment plan.
Question 3 of 5
Which one of the following compounds is not a hormone?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
Who is least likely to be treated with somatropin?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
Actions of thyroxine do not include
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.